At what enterprise value was SIMAGEC acquired in 2026?

You can find the full valuation details of SIMAGEC on mynth capital. By registering for free, you get access to complete and exact transaction details including enterprise value, revenue, and EBITDA. Additionally, our database shows that the Industry & Manufacturing industry currently tracks an average EBITDA multiple of 10.9x, providing a valuable benchmark for this transaction.

What was the EV/EBITDA of SIMAGEC when it was acquired by STERIMED?

The exact EV/EBITDA multiple for SIMAGEC is available on mynth capital. For comparison, the Industry & Manufacturing sector currently shows an average EBITDA multiple of 10.9x. Join our community for free to access full valuation data and industry trends.

When was SIMAGEC acquired by STERIMED?

SIMAGEC was acquired by STERIMED in 2026.

What was the revenue of SIMAGEC at the time of the deal?

The revenue of SIMAGEC at the time of the deal is estimated to be in the range of 5M - 25M EUR. Register for free to access the full transaction report and exact valuation multiples.

What is Enterprise Value (EV)?

Enterprise Value (EV) is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. EV includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

What is the EV/EBITDA multiple and why is it used?

The EV/EBITDA multiple is a financial ratio that compares a company's Enterprise Value (EV) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). It is widely used in M&A and valuation because it allows for comparisons between companies with different capital structures and provides a clear view of operational profitability.

How is the data for the SIMAGEC acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the SIMAGEC deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://www.paperfirst.info/the-french-group-simagec-joins-the-sterimed-adventure/

← DATABASE

Home Database Industry & ManufacturingSIMAGEC

05/2026

SIMAGEC

Acquired by

STERIMED

FRANCE Chemicals & Materials / Packaging & Containers REV 5M - 25M EUR

SIMAGEC acquired by STERIMED

FRANCE Chemicals & Materials / Packaging & Containers REV 5M - 25M EUR

Context

The acquisition of Simagec by Sterimed is a strategic move to expand Sterimed's service offering to medical device manufacturers and pharmaceutical companies. The deal complements Sterimed's existing operations and enables the company to further strengthen its position in the medical packaging market. Simagec's expertise in rigid and flexible packaging solutions, contract packaging, and validation services will enhance Sterimed's capabilities and provide a more comprehensive range of services to its customers. The acquisition is also expected to accelerate Sterimed's strategic growth in the pharmaceutical industry, where Simagec has established a strong presence. The deal is a testament to Sterimed's commitment to innovation and growth, and is expected to drive long-term value creation for the company's shareholders. With the integration of Simagec, Sterimed will be able to leverage the combined expertise and capabilities of both companies to drive growth and expansion in the medical packaging market. The acquisition is also expected to provide new opportunities for Simagec's employees and customers, as part of a larger and more diversified company.

SIMAGEC, which reported an EBITDA margin of LOGIN in 2025, is valued in this transaction at an EV/EBITDA multiple of LOGIN, a level to compare with the average currently observed in the Industry & Manufacturing sector (10.9x).

Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.

-> Deep-dive in Industry & Manufacturing market trends

Target

Simagec is a French company specializing in medical packaging solutions for the pharmaceutical industry and medical device manufacturers. With a strong expertise in rigid packaging for the medical device industry, the company has expanded its operations to provide a comprehensive range of products and services, including rigid and flexible medical packaging solutions, contract packaging for medical devices, and validation and qualification services. Simagec has also developed a business in the pharmaceutical industry, packaging disinfectant liquids in aseptic clean rooms through its subsidiary Sima Pharma. Additionally, the company designs and manufactures machinery and equipment for its own needs and for its customers in the medical sector through its engineering department, Sima Meca. With 120 employees, Simagec is a key player in the French medical packaging market, offering high-quality services to its customers. The company's expertise and capabilities make it an attractive partner for medical device manufacturers and pharmaceutical companies looking for reliable and innovative packaging solutions.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2025

2024

Other operations with SIMAGEC

REFERENCES

Revenue range: 5M - 25M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of SIMAGEC by STERIMED are reserved for mynth community members. Register for free to unlock full data.

Authors: mynth contributor (mynth data is contributed by M&A / PE professionals and systematically cross-verified with private deal documents and official press releases).

Target: simagec

Acquirer: sterimed